Yahoo Αναζήτηση Διαδυκτίου

Αποτελέσματα Αναζήτησης

1. Κυριότερες Ειδήσεις

   • Business Insider

     RBC Capital Sticks to Their Hold Rating for Adverum Biotechnologies (ADVM)

     RBC Capital analyst Lisa Walter maintained a Hold rating on Adverum Biotechnologies (ADVM – Research Report) yesterday and set a price

     17 ώρες Πριν από

   • Business Insider

     Adverum Biotechnologies (ADVM) Gets a Buy from TD Cowen

     TD Cowen analyst Joseph Thome maintained a Buy rating on Adverum Biotechnologies (ADVM – Research Report) yesterday. The company’s

     2 ημέρες Πριν από

   • 

     news.stocktradersdaily

     When (ADVM) Moves Investors should Listen

     2 εβδομάδες Πριν από

   • YAHOO!Finance

     Adverum Biotechnologies: Q3 Earnings Snapshot

     ADVM) on Monday reported a loss of $27.1 million in its third quarter. On a per-share basis, the Redwood City, California-based company said it had a loss of $1.30. The results did not meet Wall Street expectations.

     2 ημέρες Πριν από

2. finance.yahoo.com › quote › ADVMAdverum Biotechnologies, Inc. (ADVM) Latest Stock News &...

   finance.yahoo.com › quote › ADVM

   • Αποθηκευμένο αντίγραφο

   Get the latest Adverum Biotechnologies, Inc. (ADVM) stock news and headlines to help you in your trading and investing decisions.

3. markets.businessinsider.com › news › stocksAdverum Biotechnologies Reports Third Quarter 2024 Financial...

   markets.businessinsider.com › news › stocks

   • Αποθηκευμένο αντίγραφο

   2 ημέρες πριν · - 52-week LUNA and 4-year OPTIC data, alongside Phase 3 trial design updates, anticipated in Q4 2024 - Appointed Jason Mitchell as chief commercial officer - On track to initiate pivotal program ...

4. www.marketscreener.com › quote › stockAdverum Biotechnologies Reports Third Quarter 2024 Financial...

   www.marketscreener.com › quote › stock

   • Αποθηκευμένο αντίγραφο

   2 ημέρες πριν · REDWOOD CITY, Calif., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage company pioneering the use of gene therapy as a new standard of care for highly prevalent ocular diseases, today reported financial results for the third quarter of 2024 and provided updates to anticipated milestones.

5. finance.yahoo.com › quote › ADVMAdverum Biotechnologies, Inc. (ADVM) Stock Price, News, Quote &...

   finance.yahoo.com › quote › ADVM

   • Αποθηκευμένο αντίγραφο

   Find the latest Adverum Biotechnologies, Inc. (ADVM) stock quote, history, news and other vital information to help you with your stock trading and investing.

6. finance.yahoo.com › news › adverum-biotechnologies-reports-fourth-quarterAdverum Biotechnologies Reports Fourth Quarter and Full Year 2023...

   finance.yahoo.com › news › adverum-biotechnologies-reports-fourth-quarter

   • Αποθηκευμένο αντίγραφο

   18 Μαρ 2024 · REDWOOD CITY, Calif., March 18, 2024 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage company pioneering the use of gene therapy as a new standard of care for...

7. www.marketbeat.com › stocks › NASDAQAdverum Biotechnologies (ADVM) Stock Price, News & Analysis -...

   www.marketbeat.com › stocks › NASDAQ

   • Αποθηκευμένο αντίγραφο

   5 ημέρες πριν · Should You Buy or Sell Adverum Biotechnologies Stock? Get The Latest ADVM Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at MarketBeat.

8. www.google.com › finance › quoteAdverum Biotechnologies Inc (ADVM) Stock Price & News - Google

   www.google.com › finance › quote

   Get the latest Adverum Biotechnologies Inc (ADVM) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment...